Who owns DiaMedica Therapeutics Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of DMAC from SEC Form 13F filings across 88 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 88 institutions disclosed 12.5M shares of DiaMedica Therapeutics Inc. worth $87.8M — about 23.1% of shares outstanding; the largest disclosed holder is COOPERMAN LEON G. Source: SEC Form 13F filings, parsed by EvidInvest.
88
13F holders
$87.8M
value, 2026 filers
23.1%
of shares outstanding (12.5M sh)
10
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of DMAC's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | COOPERMAN LEON G | 3.5M | $24.3M | 0.7% | 6.4% | +70.8% |
| 2 | BlackRock, Inc. | 2.3M | $15.9M | 0.0% | 4.2% | +21.3% |
| 3 | GEODE CAPITAL MANAGEMENT, LLC | 894,115 | $6.3M | 0.0% | 1.7% | +14.6% |
| 4 | MILLENNIUM MANAGEMENT LLC | 845,309 | $6.0M | 0.0% | 1.6% | -9.6% |
| 5 | STATE STREET CORP | 646,743 | $4.6M | 0.0% | 1.2% | +0.4% |
| 6 | Bleichroeder LP | 382,317 | $2.7M | 0.5% | 0.7% | 0.0% |
| 7 | VANGUARD CAPITAL MANAGEMENT LLC | 355,523 | $2.5M | 0.0% | 0.7% | +6.6% |
| 8 | OSAIC HOLDINGS, INC. | 338,107 | $2.4M | 0.0% | 0.6% | +5.8% |
| 9 | NORTHERN TRUST CORP | 327,518 | $2.3M | 0.0% | 0.6% | -3.3% |
| 10 | VANGUARD PORTFOLIO MANAGEMENT LLC | 251,671 | $1.8M | 0.0% | 0.5% | +23.7% |
| 11 | LPL Financial LLC | 233,500 | $1.6M | 0.0% | 0.4% | +3.3% |
| 12 | VANGUARD FIDUCIARY TRUST CO | 207,438 | $1.5M | 0.0% | 0.4% | +10.5% |
| 13 | GOLDMAN SACHS GROUP INC | 168,066 | $1.2M | 0.0% | 0.3% | +183.5% |
| 14 | CITADEL ADVISORS LLC | 145,870 | $1.0M | 0.0% | 0.3% | +0.1% |
| 15 | Squarepoint Ops LLCNEW | 145,247 | $1.0M | 0.0% | 0.3% | new |
| 16 | Bank of New York Mellon Corp | 117,820 | $829,449 | 0.0% | 0.2% | +6.1% |
| 17 | MEMBERS WEALTH LLC | 101,382 | $713,729 | 0.4% | 0.2% | 0.0% |
| 18 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 96,691 | $680,705 | 0.0% | 0.2% | +9.4% |
| 19 | COBALT CAPITAL MANAGEMENT, INC.NEW | 90,000 | $633,600 | 0.5% | 0.2% | new |
| 20 | Trexquant Investment LP | 84,648 | $595,922 | 0.0% | 0.2% | +280.3% |
| 21 | MAGNOLIA CAPITAL ADVISORS LLC | 77,405 | $544,931 | 0.1% | 0.1% | 0.0% |
| 22 | Diametric Capital, LPNEW | 76,621 | $539,411 | 0.1% | 0.1% | new |
| 23 | GSA CAPITAL PARTNERS LLP | 72,565 | $511,000 | 0.0% | 0.1% | +24.0% |
| 24 | Blue Trust, Inc. | 69,122 | $486,619 | 0.0% | 0.1% | 0.0% |
| 25 | BANK OF AMERICA CORP /DE/ | 57,712 | $406,292 | 0.0% | 0.1% | +34.9% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.